Brain atrophy measurements should be used to guide therapy monitoring in MS - YES

Robert Zivadinov; Michael G. Dwyer; Niels Bergsland

doi:10.1177/1352458516649253

Brain atrophy measurements should be used to guide therapy monitoring in MS - YES

Neurology

University at Buffalo

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Original language	English
Pages (from-to)	1522-1524
Number of pages	3
Journal	Multiple Sclerosis
Volume	22
Issue number	12
DOIs	https://doi.org/10.1177/1352458516649253
State	Published - Oct 1 2016

Access to Document

10.1177/1352458516649253

Cite this

@article{9f792a6693e74198aa0c566ef77496f3,

title = "Brain atrophy measurements should be used to guide therapy monitoring in MS - YES",

author = "Robert Zivadinov and Dwyer, \{Michael G.\} and Niels Bergsland",

year = "2016",

month = oct,

day = "1",

doi = "10.1177/1352458516649253",

language = "English",

volume = "22",

pages = "1522--1524",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "12",

}

TY - JOUR

T1 - Brain atrophy measurements should be used to guide therapy monitoring in MS - YES

AU - Zivadinov, Robert

AU - Dwyer, Michael G.

AU - Bergsland, Niels

PY - 2016/10/1

Y1 - 2016/10/1

UR - https://www.scopus.com/pages/publications/84991325401

U2 - 10.1177/1352458516649253

DO - 10.1177/1352458516649253

M3 - Article

C2 - 27335098

SN - 1352-4585

VL - 22

SP - 1522

EP - 1524

JO - Multiple Sclerosis

JF - Multiple Sclerosis

IS - 12

ER -

Brain atrophy measurements should be used to guide therapy monitoring in MS - YES

Access to Document

Other files and links

Fingerprint

Cite this